Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract
- 12 September 2008
- journal article
- other
- Published by Wolters Kluwer Health in AIDS
- Vol. 22 (14) , 1894-1896
- https://doi.org/10.1097/qad.0b013e3283101281
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudineJournal of Antimicrobial Chemotherapy, 2008
- Infection of Semen-Producing Organs by SIV during the Acute and Chronic Stages of the DiseasePLOS ONE, 2008
- Human Immunodeficiency Virus Viral Load in Blood Plasma and Semen: Review and Implications of Empirical FindingsSexually Transmitted Diseases, 2008
- Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 QuasispeciesJournal of Clinical Microbiology, 2007
- No Virological Failure in Semen During Properly Suppressive Antiretroviral Therapy Despite Subtherapeutic Local Drug ConcentrationsHIV Research & Clinical Practice, 2006
- Lower Genitourinary Tract Sources of Seminal HIVJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Persistent HIV Type 1 Infection in Semen and Blood Compartments in Patients after Long-Term Potent Antiretroviral TherapyAIDS Research and Human Retroviruses, 2004
- Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlationsHIV Research & Clinical Practice, 2002
- Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012)AIDS, 2002
- Human Immunodeficiency Virus Type 1 in the Semen of Men Receiving Highly Active Antiretroviral TherapyNew England Journal of Medicine, 1998